1-4 of 4
Vit Pospisil, Msc.
Close
Sort by
Journal Articles

Oncogenic Micrornas In Cerebrospinal Fluid and Sera Reflect Therapy Efficacy and Their Reappearance Precedes Clinical Relapse In Primary and Secondary CNS Lymphoma

Vit Pospisil, MSc., PhD, Heidi Mocikova, MD, PhD, Magdalena Klanova, MD, Monika Palickova, MD, Tomas Kozak, M.D., Ph.D., ass. prof., Marek Trneny, MD, Ph.D., Prof., Tomas Stopka, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1777.
https://doi.org/10.1182/blood.V122.21.1777.1777
Published: 2013
Journal Articles

Mutual Regulatory Loop between miR-155 and PU.1 Is a Candidate Pathogenesis Factor in CLL.

Tomas Stopka, MD, PhD, Karin Vargova, Msc., Juraj Kokavec, Msc., Vit Pospisil, Msc., Nikola Curik, Msc., Pavel Burda, Msc., Arthur I. Skoultchi, PhD., Jiri Zavadil, PhD.
Journal: Blood
Blood (2007) 110 (11): 1130.
https://doi.org/10.1182/blood.V110.11.1130.1130
Published: 2007
Journal Articles

Fog1 and Cebpa Are DNA Targets of GATA-1/PU.1 Antagonism during Leukemia Differentiation.

Pavel Burda, Msc., Nikola Curik, Msc., Juraj Kokavec, Msc., Vit Pospisil, Msc., Arthur I. Skoultchi, PhD., Jiri Zavadil, PhD., Tomas Stopka, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 4121.
https://doi.org/10.1182/blood.V110.11.4121.4121
Published: 2007
Journal Articles

PU.1 Dose-Dependently Induces Granulocyte or Macrophage Commitment by Targeting Lineage Restricted Genes and by Regulating Transcription Factors Egr2, Nab2, Cebpa and Gfi1.

Vit Pospisil, Msc., Juraj Kokavec, Msc., Pavel Burda, Msc., Nikola Curik, Msc., Arthur I. Skoultchi, PhD., Jiri Zavadil, PhD., Tomas Stopka, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 661.
https://doi.org/10.1182/blood.V110.11.661.661
Published: 2007